
zzso primary spinal zzso zzso zzso are rare, and the optimal treatment for these zzso remains zzso We report zzso treatment outcomes of six zzso zzso managed with zzso zzso multidisciplinary zzso zzso was administered zzso with zzso zzso for two newly diagnosed primary spinal zzso zzso zzso zzso followed by zzso chemotherapy with zzso For one zzso zzso zzso and one zzso zzso zzso zzso was given as zzso therapy at first zzso One zzso transformed zzso zzso and one zzso transformed diffuse zzso zzso were treated with zzso after zzso at second zzso Two patients with newly diagnosed zzso died, 12 and 16 months, respectively, after being treated with zzso during and after radiation zzso One patient with AA and one with zzso transformed zzso showed good response to salvage therapy with zzso and had stable disease 21 and 20 months, respectively, after zzso zzso One patient with zzso zzso and one with zzso transformed zzso died from uncontrolled progression of the zzso despite zzso zzso Three patients developed grade 1 or 2 zzso zzso and zzso zzso zzso occurred in all zzso however, they were below grade 3 in zzso zzso treatment may have a positive effect on control of zzso zzso and survival for some zzso Specifically, treatment with zzso during and after radiation therapy might provide survival benefit to patients with primary spinal zzso zzso A zzso cooperative investigation for a large-scale study on zzso zzso may be zzso 

